A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer

Volume 19, Issue 1, January 2018, Pages 283-290

Yakup Bozkaya; Nuriye Yıldırım Özdemir; Ozan Yazici; Nebi Serkan Demirci; Alican Kurtipek; Gökmen Umut Erdem; Yakup Ergün; Nurullah Zengin

• View Article
• PDF 420.6 K

Comparison of Single Agent Gemcitabine and Docetaxel in Second-Line Therapy for Advanced Stage Non-Small Cell Lung Cancer in a University Hospital in Turkey

Volume 16, Issue 17, December 2015, Pages 7859-7865

• View Article
• PDF 376.52 K

Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

Volume 13, Issue 10, October 2012, Pages 5119-5124

• View Article
• PDF 457.33 K

Second-Line Irinotecan after Cisplatin, Fluoropyrimidin and Docetaxel for Chemotherapy of Metastatic Gastric Cancer

Volume 13, Issue 6, June 2012, Pages 2771-2774

• View Article
• PDF 479.19 K